Skip to main content
Article thumbnail
Location of Repository

Hepatitis C Treatment: A Community-Based, Multidisciplinary Approach to Increase Access and Improve Health Perceptions

By Elaine A. Leigh

Abstract

Hepatitis C is a major international health care dilemma, occurring frequently in populations who suffer from other health care disparities. Hepatitis C is the most common blood-borne infection and the leading cause of liver disease in the United States (U.S.), causing 10,000-12,000 deaths per year. According to the Centers for Disease Control and Preventions (2008), up to 3.9 million people are affected with the hepatitis C virus (HCV) within the US. Estimates suggest that 75% of those affected with the HCV are unaware of their diagnosis, and of those, only one in four people are offered treatment. Some researchers suggest that all US residents born between 1946 and 1970 be screened for hepatitis C over a 5-year period. The HCV carries an estimated financial burden of $10.7 billion nationally, and $377 million in Michigan alone. Barriers to treatment include the lack of qualified healthcare providers and treatment programs; rigorous treatment regimens and significant medication side effects; psychosocial challenges include mental illness; addiction; stigmatization; and insufficient healthcare coverage. The purpose of this project was improve access and care for individuals with hepatitis C in an undeserved area

Topics: Hepatitis C, multidisciplinary, practice innovation, Doctor of Nursing Practice, barriers, nurse practitioner
Publisher: ScholarWorks@GVSU
Year: 2012
OAI identifier: oai:scholarworks.gvsu.edu:dissertations-1002
Provided by: Scholarworks@GVSU

Suggested articles

Citations

  1. (2007). A
  2. (2003). A for hepatitis C services into an HIV I AIDS ..--r{'H'f,..,".....
  3. (1999). a'""
  4. Absence of hepatitis C virus from saliva semen with chronic hepatitis
  5. (2006). addicts engaged in detoxification programmes.
  6. (2009). An ethical justification for the chronic care model (CCM).
  7. (2007). An overview the diagnosis, prevention, and management hepatitis C. Gastrointestinal Nursing, 139 Poll,
  8. (2007). Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions.
  9. (2008). Capacity enhancement hepatitis C virus treatment through ....
  10. (2008). Caring for a patient with chronic l'"'IJ':tUU
  11. (2003). Chronic hepatitis C virus infection.
  12. chronic neplatl11S C in veterans: The potential integrated care models.
  13. (2008). Clinical UL"'''~M,''''L of HIV /hepatitis
  14. (2007). Developing a nursing for hepatitis Nursing
  15. (2010). development and implementation a nurse-led hepatitis C protocol for people with serious mental health problems.
  16. (2011). Education by a nurse [t;:::;PO]!l:::;t; of patients with chromc "'''''~'''T''T. therapy with peginterferon-a2a and ribavirin.
  17. (2005). Evaluation of the federal of for which h&quot;,,..,,<>t1t,,,,_r infected Hill.&quot;&quot;.'&quot; are considered for treatment. Digestive Disease and
  18. (2006). Exploring the need hepatology nurses and allied health professionals in Victorian liver
  19. (2011). Future of nursing, leading change, advancing Retrieved from !!.!:.!:~:...!.!...:::!...!.!~~~~~~~~~~~.!:.!:!!.~C£!.~~~
  20. (2009). Hepatitis C in an urban cohort: Who's not being treClLtea
  21. (2006). Hepatitis C treatment for people with severe mental illness.
  22. Hepatitis dilemma.
  23. (2002). Hepatitis Latest treatment guidelines.
  24. (2005). Hepatitis Tackling silent epidemic.
  25. (2006). Impact a designated hepatology nurse on clinical course and quality of life patients treated with Rebetron therapy chronic hepatitis Gastroenterology Nursing,
  26. (2002). Improving care for with chronic illness.
  27. (2008). in context of hepatitis C: L-OlrlCepr analysis.
  28. (2001). Increasing mortality due to &quot;''''&quot;'-'''&quot;'''''''''' liver disease immunodeficiency virus Infectious Diseases, Caldwell, L., Stafford-Fox, Combination interferon
  29. (2006). Integrated psychiatric/medical care in a chronic hepatitis C clinic: on antiviral treatment outcomes.
  30. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
  31. (2002). Knowledge of hepatitis C management by internal medicine residents: Trends over 2 The American
  32. (2008). Koop Institute 12). Hepatitis an epidemic anyone. from 130 Centers for Disease Control
  33. (2006). mana~;emlent of hepatitis C: ofa CME program.
  34. (2010). Meta-analysis: Ribavirin plus interferon vs. interferon monotherapy for chromc hepatitis C-an updated Cochrane review.
  35. (2011). Multidisciplinary program best traditional method HCV treatment. Presented at the 2011 Annual American Association for the Study of Abstract retrieved from
  36. (2009). O'M'<'''~'' of treatment in hepatitis implications for nurse specialist practice.
  37. (2003). Outcome, tolerability and v'-&quot;&quot; ....... of ,-,AVA&quot;&quot;&quot;&quot; use nt&quot;,riprnn ribavirin for h&quot;,,.,,,,+itic C infection a shared care hospital clinic.
  38. (2006). outcomes am~[)mr patients with psychiatric Rural Assistance Center
  39. (2011). Outcomes of treatment for C virus infection by primary care physicians. The New England
  40. (2010). p •. UJ'Y''''5 access to h&quot;,...&quot;&quot;,hf'.&quot;, treatment-extension for outcomes (ECHO) project: innovation in specialty care.
  41. (2008). Patient registries: central component of chromc care model.
  42. (2002). Patient selfmanagement chronic ,.u&quot;&quot;&quot;,u..;,,,&quot;, in primary care.
  43. (2009). Peginterferon plus ribavirin for chronic C in opiate addicts on methadonelbuprenorphine therapy. Digestive and Liver
  44. (2009). Perceived barriers to healthcare access among rural older adults: A qualitative study.
  45. (2007). Pretreatment preparation and management of Interferon based therapy hepatitis C virus infection.
  46. (2000). Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C.
  47. (2008). Prevalence and of hepatitis C in drug users: A Disorders Their Treatment,
  48. (2004). Providing treatment for C in an Australian rl1<'+&quot;'£'T centre.
  49. (2005). Psychiatric comorbidities among hepatitis patients. from http://focus. psychiatryonline.org/ datalJ ournalslFOCUS/261 . pdf
  50. (2008). Quality-of-life for &quot;&quot;'~'<>T',&quot;&quot; C treatment: Do providers Medical Decision Making,
  51. (2010). Retrieved from http://www.hepatitis.va.gov/patientlfaqslhow-common-is-hepatitis.asp Weiss, 1., S.
  52. (2010). Retrieved from http://www.improvingchroniccare.orglindex.php?p=The_Chronic_ Care Models&s=2 Clark
  53. (2010). retrieved from: http://www.cridata.orglGeoProfile.aspx?type=4&loc=26121
  54. retrieved www.healthvpeople.govlhp2020
  55. (2002). Risk factors for hepatitis C virus infection among homeless adults.
  56. (2011). Role the nurse practitioner the management of patients with chromc Practitioners,
  57. (2010). rpTrH&quot;&quot;'''£1 from National Health and Nutritional
  58. (2001). setting goals. management programs for hepatitis C: A team approach to IIn~rH'V
  59. (2007). stigmatization in about
  60. (2005). Teaching EBP: from zero to one. Moving from recognizing and admitting uncertainties to asking searchable, questions.
  61. (2002). The ....... &quot;&quot;0.&quot;0 treatment-associated in patients with hepatitis Gastroenterology Nursing, 25,201-203. Cto p,N'rpt,rp
  62. (2006). The <+1'-';1l'-''-' of C virus infection United States,
  63. (2010). The impact of a naIllag€~O care nprlUA,'V on attendance, follow-up, and treatment at a hepatitis e specialist centre.
  64. (2012). the United (2008). Changing trends in 1995-2004. Hepat%gy, World Health Organization.
  65. (2003). They treated me like a leper: Stigmatization and quality of of patients with ,,'&quot;'''&quot;'',
  66. (2004). to treatment e in with recent history intravenous drug
  67. (2006). Translating research into evidencebased nursing practice and evaluating effectiveness.
  68. (2007). Treatment uptake and outcomes among current and former injection drug users directly observed therapy within a multidisciplinary model for treatment of The
  69. update on treatment genotype 1 chronic hepatitis C infection: 2011 practice guideline by the for study of liver
  70. (2006). Using a simply patient to improve your chronic care. Retrieved from http://www.aatp.org/fj:nn/2006/0400/p47.html
  71. (2007). with the stigma of hepatitis

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.